Application validation of a novel nucleic acid encapsulation process (RNA, ASO, etc.)
Description
Description of the proposed partnership project: This project aims to qualify and validate the performance of an instrument for manufacturing lipid nanoparticles (LNPs) for RNA encapsulation, in a GLP to GMP-like setting. Performance criteria mainly cover the physicochemical characteristics of the LNPs and their therapeutic efficacy in vitro and in vivo.
Target participants: Nanomedicine or non-viral gene therapy manufacturing sites; CDMOs specialised in formulation or in quality control of (non-viral) nanomedicine batches.
Added value for participants: Access to the innovative equipment throughout the collaboration.
Added value for the project lead: Optimisation of the proprietary technology and user feedback on the equipment developed.
Contact: Audrey Nsamela, +33 7 67 60 10 08, audrey.nsamela@insidetx.com


